Iovance Biotherapeutics, Inc.

Direct answer

Iovance Biotherapeutics, Inc. is publicly traded on NASDAQ under the ticker IOVA.

Iovance Biotherapeutics, Inc., a biotechnology firm currently in the clinical development stage, is committed to discovering and bringing to market cancer immunotherapy solutions. Its core mission involves leveraging the patient's own immune system to effectively combat and eradicate cancerous cells. The company is presently conducting six Phase 2 clinical trials. These include study C-144-01, evaluating its primary...

Can you invest in Iovance Biotherapeutics, Inc.?

Yes. Iovance Biotherapeutics, Inc. trades publicly on NASDAQ as IOVA.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Iovance Biotherapeutics, Inc.

Detailed equity research is provided by MarketSnap.